 |
Subscribe / Renew |
 |
Contact Us |
| ► Subscribe to our Free Weekly Newsletter | |
Construction Bids
| home | Welcome, sign in or click here to subscribe. | login |
Opinion
Subscriber content preview
May 11, 2001
Cell Therapeutics poised to soar
By SAM BENNETT
Journal Staff Reporter
Journal Staff Reporter
Each week, the Daily Journal of Commerce compiles local analysts' recommendations on Northwest stocks.
Stock prices reflect Thursday's close. The Dow closed up 43 points at 10,910, and the Nasdaq fell 28 points to 2,129. The S&P 500 slipped one-third of a point to close at 1,255.
. . .
To read this story in full login or purchase a subscription.
Previous columns:
- Amazon looks good over long term, 04-27-2001
- Corixa's drug pipeline to tap market, 04-13-2001
- RealNetworks gains from music pact, 04-06-2001
- Analysts like Boeing's new focus, 03-30-2001
- Product line, market share help Tek, 03-23-2001
- Microsoft tied to slowing PC growth, 03-16-2001
- 2001 sales volumes will aid SonoSite, 03-09-2001
- Planar profits in stable medical arena, 03-02-2001